Author:
Navarro-Compán V.,Boel A.,Boonen A.,Mease P.,Landewé R.,Kiltz U.,Dougados M.,Baraliakos X.,Bautista-Molano W.,Carlier H.,Chiowchanwisawakit P.,Dagfinrud H.,de Peyrecave N.,El-Zorkany B.,Fallon L.,Gaffney K.,Garrido-Cumbrera M.,Gensler L.S.,Haroon N.,Kwan Y.H.,Machado P.M.,Maksymowych W.P.,Poddubnyy D.,Protopopov M.,Ramiro S.,Shea B.,Song IH,van Weely S.,van der Heijde D.
Funder
Meso Scale Diagnostics
Novartis
Janssen Pharmaceuticals
Roche
UCB
Pfizer
National Institute for Health Research
GlaxoSmithKline
Servier
Gilead Sciences
UCLH Biomedical Research Centre
Subject
Anesthesiology and Pain Medicine,Rheumatology
Reference39 articles.
1. Axial spondyloarthritis;Sieper;Lancet,2017
2. The future of axial spondyloathritis treatment;Maguire;Rheum Dis Clin North Am,2020
3. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis;van der Heijde;Ann Rheum Dis,2017
4. Update of the American college of rheumatology/spondylitis association of america/spondyloarthritis research and treatment network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis;Ward;Arthritis Rheumatol. 2019,2019
5. The COMET Handbook: version 1.0;Williamson;Trials,2017